相似文献
1
Knowledge, attitude and acceptance regarding bone marrow transplantation in caregivers of beta-thalassemia major patients.
J Community Genet. 2024 Dec;15(6):673-679. doi: 10.1007/s12687-024-00739-2. Epub 2024 Oct 11.
2
Knowledge, attitude and practice towards dietary iron among patients with thalassemia and their caregivers in Peninsular Malaysia.
Med J Malaysia. 2019 Oct;74(5):365-371.
3
Factors that influence caregivers' and adolescents' views and practices regarding human papillomavirus (HPV) vaccination for adolescents: a qualitative evidence synthesis.
Cochrane Database Syst Rev. 2025 Apr 15;4(4):CD013430. doi: 10.1002/14651858.CD013430.pub2.
4
Quality of Life in Children with Thalassemia and their Caregivers in India.
Indian J Pediatr. 2017 Mar;84(3):188-194. doi: 10.1007/s12098-016-2267-z. Epub 2016 Dec 7.
5
Comparison of Blood Transfusion Plus Chelation Therapy and Bone Marrow Transplantation in Patients with β-Thalassemia: Application of SF-36, EQ-5D, and Visual Analogue Scale Measures.
Int J Health Policy Manag. 2015 Jun 13;4(11):733-40. doi: 10.15171/ijhpm.2015.113.
6
[Treatment of thalassemia major with unrelated donor bone marrow transplantation].
Zhonghua Er Ke Za Zhi. 2005 Aug;43(8):599-602.
7
The influence of pediatricians' recommendation on caregivers' COVID-19 vaccine acceptance for children: A nationwide cross-sectional survey study from USA.
Front Pediatr. 2023 May 9;11:1149125. doi: 10.3389/fped.2023.1149125. eCollection 2023.
8
Knowledge, Attitude, and Perception About Renal Transplantation of CKD Patients, Caregivers, and General Population.
Transplant Proc. 2018 Oct;50(8):2323-2326. doi: 10.1016/j.transproceed.2018.04.048. Epub 2018 Apr 30.
9
Exploring the financial burden of pediatric bone marrow transplantation: a cross-sectional Study from the caregiver's viewpoint.
BMC Health Serv Res. 2025 Feb 17;25(1):262. doi: 10.1186/s12913-025-12377-6.
10
Care-Related Quality of Life of Caregivers of Beta-Thalassemia Major Children: An Epidemiological Study in Eastern India.
J Epidemiol Glob Health. 2020 Jun;10(2):168-177. doi: 10.2991/jegh.k.200102.003.
引用本文的文献
1
Quality education as a cornerstone of community genetics.
J Community Genet. 2025 Jun;16(3):217-219. doi: 10.1007/s12687-025-00794-3.
本文引用的文献
1
Exagamglogene Autotemcel: First Approval.
Mol Diagn Ther. 2024 Mar;28(2):133-139. doi: 10.1007/s40291-024-00696-z. Epub 2024 Jan 17.
2
Prevalence, Severity, and Determinants of Pain in Thalassemia.
Hemoglobin. 2023 Sep;47(5):191-197. doi: 10.1080/03630269.2023.2269846. Epub 2023 Dec 7.
3
CRISPR/Cas-based gene editing in therapeutic strategies for beta-thalassemia.
Hum Genet. 2023 Dec;142(12):1677-1703. doi: 10.1007/s00439-023-02610-9. Epub 2023 Oct 25.
4
Bone Marrow Quality Index: A Predictor of Acute Graft-versus-Host Disease in Hematopoietic Stem Cell Transplantation for Thalassemia.
Transplant Cell Ther. 2023 Nov;29(11):711.e1-711.e6. doi: 10.1016/j.jtct.2023.07.014. Epub 2023 Jul 21.
5
Clinical Challenges with Iron Chelation in Beta Thalassemia.
Hematol Oncol Clin North Am. 2023 Apr;37(2):379-391. doi: 10.1016/j.hoc.2022.12.013.
6
Prevalence and Management of β-Thalassemia in India.
Hemoglobin. 2022 Jan;46(1):27-32. doi: 10.1080/03630269.2021.2001346. Epub 2022 Feb 7.
7
Current status of beta-thalassemia and its treatment strategies.
Mol Genet Genomic Med. 2021 Dec;9(12):e1788. doi: 10.1002/mgg3.1788. Epub 2021 Nov 5.
8
Novel Therapeutic Advances in β-Thalassemia.
Biology (Basel). 2021 Jun 18;10(6):546. doi: 10.3390/biology10060546.
9
Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing.
Int J Mol Sci. 2021 Jun 10;22(12):6275. doi: 10.3390/ijms22126275.
10
A systematic review of quality of life in sickle cell disease and thalassemia after stem cell transplant or gene therapy.
Blood Adv. 2021 Jan 26;5(2):570-583. doi: 10.1182/bloodadvances.2020002948.
Zotero 插件